916862
NanoFabTx™ device accessory
tubing, 100 μm FEP, 10 m, with ferrules
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.23
UNSPSC Code:
41105100
description
Microfluidic hardware kit component:
Tubing 10m, 100μm FEP with ferrules x1
Quality Level
application(s)
advanced drug delivery
General description
NanoFabTx™ device accessory, tubing, 100 μm FEP with ferrules, 10 m is a component of our NanoFabTx™ microfluidic - micro, device kit for synthesis of 1-5 μm particles (911860). The kit additionally includes a protocol, manifold, and additional accessories for microfluidic-based synthesis. Fluorinated ethylene propylene (FEP) is a tough, flexible copolymer of tetrafluoroethylene and hexafluoropropylene, ideal for fluid processing equipment when chemical resistance, high purity, and low stiffness are required.
Application
NanoFabTx™ device accessory, tubing, 100 μm FEP with ferrules, 10 m can be used as a replacement for the component in our NanoFabTx™ microfluidic - micro, device kit for synthesis of 1-5 μm particles (911860).
Legal Information
NANOFABTX is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under NanoFabTx™ device accessory
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 916862-1EA | 04061842627837 |